News & Analysis on Clinical Trial Services & Contract Research And Development
Dutch biotech company Crucell said last week that it had completed its acquisition of SBL Vaccin in an agreement worth €39.4m, but remained tight-lipped about its plans for the Swedish firm's contract manufacturing business.
US drug developer Samaritan Pharmaceuticals has filed a patent for a new drug that could treat a wide range of neurodegenerative disorders, including Alzheimer's disease, by clearing out amyloid plaques in the brain.
Major drug companies across the US have scrambled to reformulate their over-the-counter cold medications in time for a new law that came in to effect in September, however, there are claims that the new formulations are a flop.
MultiCell Therapeutics, a recent US spin-out, has designed an anticancer therapy that has been shown in animal models to completely destroy malignant tumours, even when very advanced.
AstraZeneca has decided to make all of its clinical trials paperless and will exclusively use Medidata to assist in the process.